Clinical Trials · NCT02949362

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

CompletedPhase 3Teduglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Shire
Enrollment
29
Start date
Dec 2016
Locations
11 sites, United States, United Kingdom
Primary endpoint
Number of Participants With Adverse Events (AEs) in Retrospective Observation Period
View Teduglutide compound reference